PharmaEssentia Japan News and Activities

PharmaEssentia Japan is owned by PharmaEssentia.

PharmaEssentia is a company listed under the stock ticker 6446 (TW).

PharmaEssentia has a direct presence in 3 countries.

PharmaEssentia has 3 subsidiaries including PharmaEssentia Innovation Research Center, PharmaEssentia Japan and PharmaEssentia USA.

They are in:

• Pharmaceuticals50%
• Biotechnology50%

View the org chart displaying its 7 main executives

Most searched biographies at PharmaEssentia Japan

• Adeline Chen, Director
• Katsuya Yonezu, Chief Executive Officer
• Ko-Chung Lin, Chairman of the Board

Create your alert
to follow the executive moves at PharmaEssentia Japan.

PharmaEssentia has 2,405 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by PharmaEssentia Japan

Social media about PharmaEssentia Japan

• PharmaEssentia Japan on Wikipedia, Google News & Yahoo Finance
• PharmaEssentia Japan on LinkedIn, X (Twitter) & YouTube